DOCS

Doximity, Inc. 10-Q Summary: Quarter Ended December 31, 2024

Business Context and Reporting Period

This filing covers the quarterly period ended December 31, 2024, representing the third quarter of Doximity's fiscal year 2025 (which ends March 31). Doximity operates as the leading digital platform for U.S. medical professionals, serving over 80% of U.S. physicians. The company generates revenue primarily through Marketing Solutions (content delivery to physicians) and Hiring Solutions (recruiting tools for health systems and pharma companies).

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 25% year-over-year in Q3 2024, driven by a $32.8 million increase in subscription revenue. This was split between $7.6 million from new customers and $25.2 million from expansion of existing customers (average revenue per Marketing Solutions customer increased ~24%).
• Profitability Expansion: Net income margin expanded to 45% in Q3 2024 from 35% in the prior year, aided by operating leverage and higher interest income.
• Operating Expenses:
  • R&D: Increased 12% YoY, primarily due to higher stock-based compensation and personnel costs.
  • Sales & Marketing: Increased 10% YoY, driven by stock-based compensation and sales incentives, partially offset by lower personnel costs due to prior headcount reductions.
  • G&A: Increased 41% YoY, largely due to a $3.4 million increase in stock-based compensation.
• Other Income: Increased 121% YoY to $9.9 million, driven by higher yields on the company's cash and marketable securities portfolio.
• Impairment Charges: A $2.3 million impairment charge was recorded in the nine months ended Dec 31, 2024, related to a sublease of office space in Irving, Texas. This compares to $7.9 million in restructuring charges in the same period of 2023.

Guidance, Outlook, and Risks

• Share Repurchases: The company has an active program to repurchase up to $500 million of Class A common stock. As of December 31, 2024, $450.8 million remains available. The company repurchased 394,871 shares in Q3 2024.
• Liquidity: Management believes existing cash and marketable securities ($844.9 million) are sufficient to meet liquidity needs for at least the next 12 months.
• Legal Proceedings: The company is facing a securities class action lawsuit and three shareholder derivative lawsuits filed in April 2024 regarding disclosures of user counts and engagement rates. The company intends to defend vigorously but cannot predict the outcome or estimate potential losses at this early stage.
• Tax Strategy: The company purchased $13.8 million of transferable tax credits in Q3 2024 and is committed to purchasing an additional $15.7 million as projects are placed in service.
• Forward-Looking Statements: The filing includes standard disclaimers regarding risks related to competition, regulatory changes, data privacy, and the ability to retain members and customers.

Key Facts for Investor Verification

• Customer Concentration: No single customer represented 10% or more of revenue in the period; however, Customer A represented 12% of accounts receivable as of Dec 31, 2024.
• Net Revenue Retention: The Net Revenue Retention Rate was 117% for the trailing 12 months ended Dec 31, 2024, indicating strong expansion within the existing customer base.
• Stock-Based Compensation: Total stock-based compensation expense was $54.3 million for the nine months ended Dec 31, 2024, a significant non-cash expense impacting net income but excluded from Adjusted EBITDA.
• Legal Exposure: Verify the status of the securities litigation filed in April 2024, as the outcome could materially impact financial results or reputation.
• Capital Allocation: Monitor the pace of share repurchases under the remaining $450.8 million authorization and the impact of the 1% excise tax on net repurchases.